Clinical trials remain essential to evaluate combination immunotherapies, and against a broader range of cancers Journal Article
| Author: | Wolchok, J. |
| Article Title: | Clinical trials remain essential to evaluate combination immunotherapies, and against a broader range of cancers |
| Keywords: | antibodies, monoclonal; clinical trials; neoplasms -- drug therapy; immunotherapy -- methods |
| Journal Title: | Oncology Times |
| Volume: | 35 |
| Issue: | 21 |
| ISSN: | 0276-2234 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2013-11-10 |
| Start Page: | 34 |
| End Page: | 34 |
| Language: | English |
| ACCESSION: | 2012388251 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI: | 10.1097/01.COT.0000437978.33811.08 |
| DOI/URL: | |
| Notes: | Accession Number: 2012388251 -- Entry Date: 20131220 -- Publication Type: journal article -- Journal Subset: Biomedical; Peer Reviewed; USA -- Special Interest: Oncologic Care -- NLM UID: 8100849. -- Source: cin20 |
